awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39022581-80F84C23-E2C9-482E-BF29-D433F4C89580
Q39022581-80F84C23-E2C9-482E-BF29-D433F4C89580
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39022581-80F84C23-E2C9-482E-BF29-D433F4C89580
PCSK9 in chronic kidney disease.
P2860
Q39022581-80F84C23-E2C9-482E-BF29-D433F4C89580
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39022581-80F84C23-E2C9-482E-BF29-D433F4C89580
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a53adeb4bd7ea56366990b4d704e3ed00071652
P2860
Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS S